Hinge Health
(NYSE) HNGE
Hinge Health Financials at a Glance
Market Cap
$5.81B
Revenue (TTM)
$646.34M
Net Income (TTM)
-$510.27M
EPS (TTM)
-$6.59
P/E Ratio
-11.41
Dividend
$0.00
Beta (Volatility)
0.25 (Low)
Dividend
$0.00
Beta (Volatility)
0.25 (Low)
Price
$78.82
Volume
67,186
Open
$75.24
Price
$78.82
Volume
67,186
Open
$75.24
Previous Close
$78.82
Daily Range
$74.48 - $79.27
52-Week Range
$30.08 - $79.27
Estimated Earnings Date
Aug 4, 2026
Dividend
$0.00
Beta (Volatility)
0.25 (Low)
Price
$78.82
Volume
67,186
Open
$75.24
Previous Close
$78.82
Daily Range
$74.48 - $79.27
52-Week Range
$30.08 - $79.27
Estimated Earnings Date
Aug 4, 2026
HNGE News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Hinge Health
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
143
CEO
Daniel Perez, PhD
Website
www.hingehealth.comHeadquarters
San Francisco, CA 94105, US
HNGE Financials
Key Financial Metrics (TTM)
Gross Margin
80.83%
Operating Margin
-81.60%
Net Income Margin
-78.95%
Return on Equity
-138.70%
Return on Capital
-141.34%
Return on Assets
-70.02%
Earnings Yield
-8.76%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$5.81B
Shares Outstanding
77.38M
Volume
67.19K
Avg. Volume
1.49M
Financials (TTM)
Gross Profit
$522.41M
Operating Income
-$527.44M
EBITDA
-$521.93M
Operating Cash Flow
$209.60M
Capital Expenditure
-$3.44M
Free Cash Flow
$206.17M
Cash & ST Invst.
$317.31M
Total Debt
$6.97M
Hinge Health Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$182.31M
+47.2%
Gross Profit
$154.23M
+53.9%
Gross Margin
84.60%
N/A
Market Cap
$5.81B
N/A
Market Cap/Employee
$3.84M
N/A
Employees
1,514
N/A
Net Income
$35.13M
-71.0%
EBITDA
$33.24M
+143.7%
Quarterly Fundamentals
Total Cash
$317.31M
-32.6%
Total Debt
$6.97M
-31.2%
Accounts Receivable
$114.92M
+51.4%
Inventory
$36.02M
+181.7%
Long Term Debt
$2.74M
-56.1%
Short Term Debt
$4.23M
+8.6%
Return on Assets
-70.02%
N/A
Return on Invested Capital
-1.68%
N/A
Free Cash Flow
$43.00M
+931.7%
Operating Cash Flow
$43.08M
+774.8%